vs
CytoMed Therapeutics Ltd（GDTC）与MICROVISION, INC.（MVIS）财务数据对比。点击上方公司名可切换其他公司
MICROVISION, INC.的季度营收约是CytoMed Therapeutics Ltd的1.9倍（$223.0K vs $115.4K），CytoMed Therapeutics Ltd自由现金流更多（$-855.4K vs $-59.4M）
CytoMed Therapeutics是一家临床阶段生物制药企业，专注于开发同种异体CAR-T细胞疗法，用于治疗血液恶性肿瘤与实体瘤，深耕肿瘤免疫领域，致力于满足全球癌症患者未被满足的临床治疗需求。
MicroVision Inc.是一家专注于激光雷达传感器、微型显示解决方案与感知软件研发的科技企业，核心产品覆盖车载高级驾驶辅助系统、AR设备、消费电子及工业自动化等领域，为各类下一代智能应用提供高精度、低功耗的技术支持。
GDTC vs MVIS — 直观对比
营收规模更大
MVIS
是对方的1.9倍
$115.4K
自由现金流更多
GDTC
多$58.5M
$-59.4M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.4K | $223.0K |
| 净利润 | — | — |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | — | — |
| 营收同比 | — | -86.5% |
| 净利润同比 | — | -21.2% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDTCMVIS
| Q4 25 | — | $223.0K | ||
| Q3 25 | — | $241.0K | ||
| Q2 25 | $115.4K | $155.0K | ||
| Q1 25 | — | $589.0K | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $190.0K | ||
| Q2 24 | — | $1.9M | ||
| Q1 24 | — | $956.0K |
净利润GDTCMVIS
| Q4 25 | — | — | ||
| Q3 25 | — | $-14.2M | ||
| Q2 25 | — | $-14.2M | ||
| Q1 25 | — | $-28.8M | ||
| Q4 24 | — | $-31.2M | ||
| Q3 24 | — | $-15.5M | ||
| Q2 24 | — | $-23.9M | ||
| Q1 24 | — | $-26.3M |
毛利率GDTCMVIS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | — | -149.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 18.2% | ||
| Q1 24 | — | -33.6% |
营业利润率GDTCMVIS
| Q4 25 | — | — | ||
| Q3 25 | — | -5278.4% | ||
| Q2 25 | — | -9455.5% | ||
| Q1 25 | — | -2383.7% | ||
| Q4 24 | — | -1119.5% | ||
| Q3 24 | — | -8266.3% | ||
| Q2 24 | — | -1296.4% | ||
| Q1 24 | — | -2793.9% |
净利率GDTCMVIS
| Q4 25 | — | — | ||
| Q3 25 | — | -5899.2% | ||
| Q2 25 | — | -9180.0% | ||
| Q1 25 | — | -4886.1% | ||
| Q4 24 | — | -1888.2% | ||
| Q3 24 | — | -8166.8% | ||
| Q2 24 | — | -1259.5% | ||
| Q1 24 | — | -2752.4% |
每股收益（稀释后）GDTCMVIS
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | — | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $74.9M |
| 总债务越低越好 | — | $19.2M |
| 股东权益账面价值 | — | $55.5M |
| 总资产 | — | $103.1M |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资GDTCMVIS
| Q4 25 | — | $74.9M | ||
| Q3 25 | — | $99.5M | ||
| Q2 25 | — | $91.4M | ||
| Q1 25 | — | $69.0M | ||
| Q4 24 | — | $74.7M | ||
| Q3 24 | — | $43.2M | ||
| Q2 24 | — | $56.6M | ||
| Q1 24 | — | $73.1M |
总债务GDTCMVIS
| Q4 25 | — | $19.2M | ||
| Q3 25 | — | $29.0M | ||
| Q2 25 | — | $32.3M | ||
| Q1 25 | — | $30.1M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GDTCMVIS
| Q4 25 | — | $55.5M | ||
| Q3 25 | — | $90.7M | ||
| Q2 25 | — | $77.1M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | — | $48.8M | ||
| Q3 24 | — | $65.9M | ||
| Q2 24 | — | $78.7M | ||
| Q1 24 | — | $93.8M |
总资产GDTCMVIS
| Q4 25 | — | $103.1M | ||
| Q3 25 | — | $150.8M | ||
| Q2 25 | — | $140.6M | ||
| Q1 25 | — | $116.7M | ||
| Q4 24 | — | $121.2M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | — | $103.4M | ||
| Q1 24 | — | $124.2M |
负债/权益比GDTCMVIS
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.42× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | 0.68× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-855.3K | $-58.7M |
| 自由现金流经营现金流 - 资本支出 | $-855.4K | $-59.4M |
| 自由现金流率自由现金流/营收 | -741.5% | -26636.3% |
| 资本支出强度资本支出/营收 | 0.0% | 304.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-103.1M |
8季度趋势，按日历期对齐
经营现金流GDTCMVIS
| Q4 25 | — | $-58.7M | ||
| Q3 25 | — | $-16.5M | ||
| Q2 25 | $-855.3K | $-12.7M | ||
| Q1 25 | — | $-14.1M | ||
| Q4 24 | — | $-15.1M | ||
| Q3 24 | — | $-14.1M | ||
| Q2 24 | — | $-18.6M | ||
| Q1 24 | — | $-20.8M |
自由现金流GDTCMVIS
| Q4 25 | — | $-59.4M | ||
| Q3 25 | — | $-16.6M | ||
| Q2 25 | $-855.4K | $-12.9M | ||
| Q1 25 | — | $-14.2M | ||
| Q4 24 | — | $-15.2M | ||
| Q3 24 | — | $-14.1M | ||
| Q2 24 | — | $-18.8M | ||
| Q1 24 | — | $-20.9M |
自由现金流率GDTCMVIS
| Q4 25 | — | -26636.3% | ||
| Q3 25 | — | -6894.6% | ||
| Q2 25 | -741.5% | -8346.5% | ||
| Q1 25 | — | -2410.4% | ||
| Q4 24 | — | -918.7% | ||
| Q3 24 | — | -7421.1% | ||
| Q2 24 | — | -989.5% | ||
| Q1 24 | — | -2183.4% |
资本支出强度GDTCMVIS
| Q4 25 | — | 304.5% | ||
| Q3 25 | — | 53.1% | ||
| Q2 25 | 0.0% | 134.2% | ||
| Q1 25 | — | 16.8% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | — | 4.7% | ||
| Q2 24 | — | 8.7% | ||
| Q1 24 | — | 11.9% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
